ELISA assay for quantitative and qualitative analysis of exosomes
Reference:
Musante, L., Tataruch-Weinert, D., Kerjaschki, D., Henry, M., Meleady, P., & Holthofer, H. (2017). Residual extracellular urinary vesicles in ultracentrifugation supernatants after enrichment by dialysis by hydrostatic filtration. Journal of Extracellular Vesicles, 6 (1), 1267896.
Foster, B. P., Balassa, T., Benen, T. D., Dominovic, M., Elmadjian, G. K., Florova, V., … & Kyvelidou, C. (2016). Extracellular vesicles in the blood, milk and body fluids of the female and male urogenital tracts and with special regard to reproduction. Critical Reviews in Clinical Laboratory Sciences, (just accepted), 1-47.
Tas, F., Karabulut, S., Tilgen Yasasever, C., & Duranyildiz, D. (2015). Clinical significance of serum caveolin -1 levels in patients with melanoma. International Journal of Dermatology.
Zarovni, N., Corrado, A., Guazzi, P., Zocco, D., Lari, E., Radano, G., … & Chiesi, A. (2015). Integrated isolation and quantitative analysis of exosome-transmitted proteins and nucleic acids using immunocapsura approaches.
Exo-TEST: ready to use ELISA quantification kits
ExoTEST is a patented double sandwich ELISA assay for quantitative and qualitative analysis of exosomes. In particular ExoTEST is a successful platform for exosomes quantification and characterization from small amount of human biological fluids or cell media and it may be exploited to identify exosomes released by cancer cells in the plasma and urine of tumor patients in various disease conditions.
ExoTEST consists of ELISA plates pre-coated with patented panexosome antibodies that allow specific capture of exosomes from a variety of biological samples, including cell culture supernatants and human biological fluids. Quantification and characterization of exosomal proteins is then performed using appropriate detection antibodies against exosome-associated antigens, which can be either generic or cell / tissue specific exosomes. Lyophilized exosome standards characterized by protein content and particle number (NTA) allow the quantification of an unknown sample by a standard calibration curve.
Applications: Capture and quantification of exosomes from human biofluids and culture media. Exosome complex profiling. Preclinical research on non-invasive biomarkers for the detection and monitoring of a number of pathological conditions (inflammation, cancer, neurodegeneration, etc.).
Advantages: Ready to use, no initial purification of exosomes is required. User-friendly and suitable for the analysis of multiple markers. Available in TEST format (limited to 3 ELISA strips, 24 wells).
Methods.
Miller, I. V., & Grunewald, T. G. (2015). Tumor-derived exosomes: Tiny envelopes for big stories. Biology of the Cell, 107 (9), 287-305.
Hong, C. S., Muller, L., Boyiadzis, M., & Whiteside, T. L. (2014). Isolation and characterization of CD34 + blast-derived exosomes in acute myeloid leukemia. PLoS One, 9 (8), e103310.
Tetta, C., Ghigo, E., Silengo, L., Deregibus, M. C., & Camussi, G. (2013). Extracellular vesicles as an emerging mechanism of communication between cells. Endocrine, 44 (1), 11-19.
Vishnubhatla, I., Corteling, R., Stevanato, L., Hicks, C., & Sinden, J. (2014). Development of stem cell-derived exosomes as cell-free regenerative medicine. J. Circ. Biomark, 143, 2.
Logozzi, M., De Milito, A., Lugini, L., Borghi, M., Calabrò, L., Spada, M., … & Fais, S. (2009). High levels of exosomes expressing CD63 and caveolin-1 in the plasma of patients with melanoma. (4), e5219.
 Primary Human Hepatocytes, Transporter Uptake Qualified | |||
| T0125 | ABM | 5x10^5 cells / 1.0 ml | EUR 3500 |
 Primary Human Hepatocytes, Induction Qualified, Plateable | |||
| T0128 | ABM | 5x10^5 cells / 1.0 ml | EUR 2625 |
 YASESMSGIPSR* - SIL Infliximab signature peptide qualifier | |||
| SB289 | Smartox Biotechnology | 0.1 | EUR 409.06 |
Description: Secondary SIL peptide for Infliximab detection and quantification | |||
 Primary Human Hepatocytes, Metabolism Qualified, Plateable | |||
| T0124 | ABM | 5x10^5 cells / 1.0 ml | EUR 2625 |
 Primary Human Hepatocytes, Metabolism Qualified, Suspension | |||
| T0123 | ABM | 5x10^5 cells / 1.0 ml | EUR 1375 |
 ASQSIGTNIHWYQQR* - SIL Cetuximab signature peptide qualifier | |||
| SB293 | Smartox Biotechnology | 0.1 | EUR 409.06 |
Description: Secondary SIL peptide for Cetuximab detection and quantification | |||
) FBS - Heat Inactivated Qualified Imported Fetal Bovine Serum (USDA Approved) | |||
| FBS006-HI | Neuromics | each | EUR 279 |
 QAPGQGLEWMGDINTR* - SIL Emicizumab signature peptide qualifier | |||
| SB300 | Smartox Biotechnology | 0.1 | EUR 409.06 |
Description: Secondary SIL peptide for Emicizumab detection and quantification | |||
) FBS-Heat Inactivated Qualified Imported Fetal Bovine Serum (USDA Approved) | |||
| MBS555998-500mL | MyBiosource | 500mL | EUR 385 |
FBS-Heat Inactivated Qualified Imported Fetal Bovine Serum (USDA Approved) | |||
| MBS555998-5x500mL | MyBiosource | 5x500mL | EUR 1590 |
 GLEWIGAIYPGNGDTSYNQK* - SIL Rituximab signature peptide qualifier | |||
| SB291 | Smartox Biotechnology | 0.1 | EUR 409.06 |
Description: Secondary SIL peptide for Rituximab detection and quantification | |||
 SLEWIGAIDPYYGGTSYNQK* – SIL Dinutuximab signature peptide qualifier | |||
| SB297 | Smartox Biotechnology | 0.1 | EUR 409.06 |
Description: Secondary SIL peptide for Dinutuximab detection and quantification | |||
 QuantiFluo DNA Assay Kit | |||
| QFDN-250 | BioAssay Systems | 250 | EUR 369 |
 QuantiChrom Iron Assay Kit | |||
| DIFE-250 | BioAssay Systems | 250 | EUR 439 |
 QuantiChrom Heme Assay Kit | |||
| DIHM-250 | BioAssay Systems | 250 | EUR 399 |
 QuantiChrom Zinc Assay Kit | |||
| DIZN-250 | BioAssay Systems | 250 | EUR 499 |
 QuantiChrom FRAP Assay Kit | |||
| DFRAP-250 | BioAssay Systems | 250 | EUR 399 |
 QuantiChromHydroxyproline Assay Kit | |||
| DHYP-100 | BioAssay Systems | 100 | EUR 499 |
 QuantiChrom TBARS Assay Kit | |||
| DTBA-100 | BioAssay Systems | 100 | EUR 259 |
 QuantiChrom Boron Assay Kit | |||
| DBOR-100 | BioAssay Systems | 100 | EUR 359 |
 QuantiChrom Urease Assay Kit | |||
| DURE-100 | BioAssay Systems | 100 | EUR 449 |
 QuantiFluo Ammonia Assay Kit | |||
| DNH3-200 | BioAssay Systems | 200 | EUR 199 |
 QuantiChrom Biotin Assay Kit | |||
| DBIO-100 | BioAssay Systems | 100 | EUR 239 |
 QuantiChrom Lipase Assay Kit | |||
| DLPS-100 | BioAssay Systems | 100 | EUR 489 |
 QuantiChrom Copper Assay Kit | |||
| DICU-250 | BioAssay Systems | 250 | EUR 499 |
 QuantiChrom Indole Assay Kit | |||
| DIND-100 | BioAssay Systems | 100 | EUR 209 |
 QuantiChrom Cobalt Assay Kit | |||
| DCBT-100 | BioAssay Systems | 100 | EUR 509 |
 QuantiFluo Protein Assay Kit | |||
| QFPR-200 | BioAssay Systems | 200 | EUR 169 |
 QuantiChrom Phytase Assay Kit | |||
| DPHT-100 | BioAssay Systems | 100 | EUR 419 |
 QuantiChrom Sulfate Assay Kit | |||
| DSFT-200 | BioAssay Systems | 200 | EUR 389 |
 QuantiChrom Calcium Assay Kit | |||
| DICA-500 | BioAssay Systems | 500 | EUR 399 |
 QuantiChrom Indican Assay Kit | |||
| DIDC-01K | BioAssay Systems | 1000 | EUR 439 |
QuantiChrom Indican Assay Kit | |||
| DIDC-100 | BioAssay Systems | 100 | EUR 329 |
 QuantiChrom Ethanol Assay Kit | |||
| DIET-500 | BioAssay Systems | 500 | EUR 499 |
 QuantiChrom Glucose Assay Kit | |||
| DIGL-100 | BioAssay Systems | 100 | EUR 329 |
 QuantiChrom Protein Assay Kit | |||
| QCPR-500 | BioAssay Systems | 500 | EUR 259 |
 QuantiFluo Urokinase Assay Kit | |||
| DUKN-100 | BioAssay Systems | 100 | EUR 399 |
 QuantiChrom Chloride Assay Kit | |||
| DICL-250 | BioAssay Systems | 250 | EUR 349 |
 QuantiChrom Peroxide Assay Kit | |||
| DIOX-250 | BioAssay Systems | 250 | EUR 369 |
 QuantiChrom Carbonyl Assay Kit | |||
| DCAR-100 | BioAssay Systems | 100 | EUR 369 |
 QuantiChrom Chromium Assay Kit | |||
| DCRM-250 | BioAssay Systems | 250 | EUR 479 |